Publication | Open Access
SMARCA2 deficiency in NSCLC: a clinicopathologic and immunohistochemical analysis of a large series from a single institution
12
Citations
30
References
2022
Year
In conclusion, SMARCA2-negative expression is an independent predictor of a poor outcome of NSCLC and is a potential target for NSCLC treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1